Analysis: U.S. foreign bribery penalties for drugmakers may lack bite

outterson_white-new_65wReuters
Kevin Outterson, School of Law

Global drugmakers are paying tens of millions of dollars to settle U.S. allegations that they bribed their way across emerging markets, but harsher penalties may be needed to deter the practice in untapped regions where billions are at stake…

View article